Neurocrine Biosciences Inc (NASDAQ:NBIX)

75.51
Delayed Data
As of Jan 26
 -0.42 / -0.55%
Today’s Change
71.88
Today|||52-Week Range
120.01
-11.34%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 120.00, with a high estimate of 154.00 and a low estimate of 69.00. The median estimate represents a +58.92% increase from the last price of 75.51.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.68
Sales
$318.0M
Reporting Date
Feb 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 193.70%
 
 
 
 
 
 
Growthannually -54.56%
 
 
 
 
 
 

Sales

Growthquarterly 7.45%
 
 
 
 
 
 
Growthannually 8.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.